What question did this study set out to answer?

April 28, 2026Journal of the American Society for Mass Spectrometry0 citations

Roles of FXR in Lipid Biochemistry within Hepatocellular Carcinoma Using MALDI MSI

KBK. Bender YHYing Hu BTBlanca R. Teodoro

Key Points

The study aims to explore the role of FXR in lipid biochemistry within hepatocellular carcinoma by analyzing lipid profiles.
Utilized matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI MSI) to profile liver lipids.
Focused on identifying differences in phosphatidylcholine species between HCC and adjacent tissues.
Conducted cell culture experiments with Hep3B cells exposed to PC(38:4) to assess effects on HCC.
Distinct spatial differences in phosphatidylcholine lipids were found between HCC and non-tumorous liver tissues.
PC(38:4) was identified as a significant lipid species associated with hepatocellular carcinoma in cell culture experiments.

Abstract

Hepatocellular carcinoma (HCC) is a common type of cancer with a high mortality rate, which is affected by the farnesoid X receptor (FXR) in the liver. FXR is a ligand-activated nuclear receptor involved in lipid metabolism and homeostasis. Matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI MSI) enables spatially resolved molecular analysis and is particularly suited to profiling lipid distributions within tissues. In this study, MALDI MSI was employed to investigate alterations in liver lipid composition associated with HCC and FXR expression with a focus on phosphatidylcholine (PC) species. Distinct spatial and compositional differences in PC lipids were observed between HCC and nontumorous regions. Furthermore, we hypothesize a role of PC(38:4) in HCC based on cell culture experiments in which Hep3B cells were incubated in the presence of PC(38:4).

KI fragen

Bookmark

View Full Paper